Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Safety of antiemetic prophylaxis with HTX-019 as a 30-min infusion in patients with cancer: a retrospective study.
Journal: Future oncology (London, England)
Published: January 28, 2020
Does site-of-care for oncology infusion therapy influence treatment patterns, cost, and quality in the United States?
Journal: Journal of medical economics
Published: September 26, 2017
A retrospective cohort study to assess the impact of therapeutic substitution of darbepoetin alfa for epoetin alfa in anemic patients with myelodysplastic syndrome.
Journal: The journal of supportive oncology
Published: December 15, 2005
Effectiveness of darbepoetin alfa versus epoetin alfa in patients with chemotherapy-induced anemia treated in clinical practice.
Journal: The oncologist
Published: July 22, 2004
Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
Journal: The oncologist
Published: February 03, 2004
Showing 1-6 of 6
Last Updated: 09/26/2026